CBS News
@CBSNews·7M subscribers·153.5K videos
The impact of the FDA's approval of the first 'biosimilar' drug
Posted
March 7, 2015
Views
1,440
Likes
7
Engagement
0.49%
March 7, 2015
1,440
7
0.49%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
2:04Now PlayingOn Friday, the FDA approved a "biosimilar" version of the cancer drug Neupogen. CBS News chief medical correspondent Dr. Jon LaPook explains how the new technique could lower the enormous cost of expensive drugs.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
